Li Y - Search Results

1

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen.

Fan Y, Li Y, Chen Y, Yu J, Liu X, Li W, Guo B, Li X, Wang J, Wu H, Wang Y, Hu J, Guo Y, Hu F, Xu X, Cao G, Wu J, Zhang Y, Zhang J, Wu X. Fan Y, et al. Among authors: li y, li w, li x. Antibiotics (Basel). 2022 Jun 14;11(6):798. doi: 10.3390/antibiotics11060798. Antibiotics (Basel). 2022. PMID: 35740204 Free PMC article.

2

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations.

Wang Y, Liu X, Li K, Fan Y, Yu J, Wu H, Li Y, Wu X, Guo B, Li X, Hu J, Wu J, Cao G, Zhang J. Wang Y, et al. Among authors: li y, li x, li k. Antibiotics (Basel). 2022 Jul 16;11(7):958. doi: 10.3390/antibiotics11070958. Antibiotics (Basel). 2022. PMID: 35884212 Free PMC article.

3

Development and validation of ultra-performance liquid chromatography-tandem mass spectrometric methods for simultaneous and rapid determination of contezolid and its major metabolite M2 in plasma and urine samples and its application to a study in subjects with moderate liver impairment.

Wang Y, Wu H, Wu J, Fan Y, Liu X, Li Y, Hu J, Zhang J, Guo B. Wang Y, et al. Among authors: li y. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Feb 15;1191:123129. doi: 10.1016/j.jchromb.2022.123129. Epub 2022 Jan 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35066246

4

Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis.

Guo B, He G, Wu X, Yu J, Cao G, Li Y, Fan Y, Chen Y, Shi Y, Zhang Y, Zhang J. Guo B, et al. Among authors: li y. Clin Ther. 2017 Jul;39(7):1336-1346. doi: 10.1016/j.clinthera.2017.05.350. Epub 2017 Jun 12. Clin Ther. 2017. PMID: 28619503 Clinical Trial.

5

Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study.

Wang Y, Xu C, Zhang R, Chen Y, Shen Y, Hu F, Liu D, Lu J, Guo Y, Xia X, Jiang J, Wang X, Fu Y, Yang L, Wang J, Li J, Cai C, Yin D, Che J, Fan R, Wang Y, Qing Y, Li Y, Liao K, Chen H, Zou M, Liang L, Tang J, Shen Z, Wang S, Yang X, Wu C, Xu S, Walsh TR, Shen J. Wang Y, et al. Among authors: li y, li j. Lancet Infect Dis. 2020 Oct;20(10):1161-1171. doi: 10.1016/S1473-3099(20)30149-3. Epub 2020 Jun 4. Lancet Infect Dis. 2020. PMID: 32505232

6

Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.

Zhao Z, Bao L, Yu X, Zhu C, Xu J, Wang Y, Yin M, Li Y, Li W. Zhao Z, et al. Among authors: li y, li w. Medicine (Baltimore). 2017 Sep;96(36):e8009. doi: 10.1097/MD.0000000000008009. Medicine (Baltimore). 2017. PMID: 28885366 Free PMC article.

7

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real-world study for patients with hormone receptor-positive and HER2-negative advanced breast cancer.

Zhao Y, Li Y, Gong C, Xie Y, Zhang J, Wang L, Cao J, Tao Z, Wang B, Hu X. Zhao Y, et al. Among authors: li y. Cancer Med. 2020 Dec;9(23):8821-8831. doi: 10.1002/cam4.3491. Epub 2020 Oct 6. Cancer Med. 2020. PMID: 33022852 Free PMC article.

8

A Rare Case of Retroperitoneal Follicular Dendritic Cell Sarcoma Identified by 99mTc-HYNIC-TOC SPECT/CT.

Li Y, Xu X, Xu J, Huang D. Li Y, et al. Clin Nucl Med. 2018 Aug;43(8):599-601. doi: 10.1097/RLU.0000000000002150. Clin Nucl Med. 2018. PMID: 29863574

9

Heterogeneity derived from ¹⁸ F-FDG PET/CT predicts immunotherapy outcome for metastatic triple-negative breast cancer patients.

Xie Y, Liu C, Zhao Y, Gong C, Li Y, Hu S, Song S, Hu X, Yang Z, Wang B. Xie Y, et al. Among authors: li y. Cancer Med. 2022 May;11(9):1948-1955. doi: 10.1002/cam4.4522. Epub 2022 Mar 11. Cancer Med. 2022. PMID: 35275444 Free PMC article.

10

Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer.

Li Y, Zhao Y, Gong C, Xie Y, Hu X, Zhang J, Wang L, Zhang S, Cao J, Tao Z, Wang B. Li Y, et al. Sci Rep. 2019 Mar 5;9(1):3563. doi: 10.1038/s41598-019-39314-y. Sci Rep. 2019. PMID: 30837503 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222,122 results

Search Page